Hematology/Oncology and Bone Marrow Transplantation

Director, Blood and Marrow Transplantation Program
Medical Director, Blood and Marrow Processing Laboratory
Assistant Professor of Pediatrics, University of Pittsburgh School of Medicine


Division of Pediatric Hematology/Oncology
Children's Hospital of Pittsburgh
3705 Fifth Ave.
Pittsburgh, PA 15213

412-692-5055
412-692-7693 Fax
rakesh.goyal@chp.edu
Patient Appointment Information

Medical School:

1983 University of Delhi, India

Residency:

Lok Nayak Jai Prakash Narain Hospital, Delhi, India
University of Connecticut Health Center, Farmington, CT

Fellowship:

University of Connecticut Health Center, Farmington, CT
Washington University School of Medicine, St. Louis, MO

• American Society of Hematology
• American Society for Blood and Marrow Transplantation
• International Society for Cellular Therapy

• American Board of Pediatrics
• American Board of Pediatrics, Subspecialty of Hematology/Oncology
• State Board of Medical Examiners

• Outstanding Achievement in Patient Care Award

• Pediatric Blood and Marrow Transplant Consortium/Clinical Trials Network
• Cellular and Molecular Studies in Bone Marrow Transplantation

Dr. Goyal received his medical degree from the University of Delhi, India. After his residency in Pediatrics at the University of Connecticut Health Center, he completed clinical fellowship in Hematology/Oncology at the St. Louis Children's Hospital. He also conducted research in molecular mechanisms of blood formation during embryonic development at the Washington University School of Medicine, St. Louis. He is board certified in Pediatrics and Pediatric Hematology/Oncology. He is assistant professor of Pediatrics at the University of Pittsburgh and director of the Blood and Marrow Transplantation program at Children's Hospital of Pittsburgh. He is principal investigator for the Pediatric Blood and Marrow Transplant Consortium and serves on the national committee for graft-versus host disease.

Dr. Goyal's clinical research is focused on understanding the relationship between individual genetic variability and outcome of transplant therapy. He and his team are studying ways by which we may be able to predict the risk of serious complications such as graft-versus-host disease and how that might lead to individualized therapy. His team is dedicated to developing novel regimens in reducing toxicities of transplant and exploring the use of alternative sources of stem cells such as umbilical cord blood for transplantation in children.